Was the FDA Peptide Ban Lifted? (October 2026)
Pending medical review
Short answer: Not yet. On October 14, 2026, the FDA sent an "Interim Access Policy for Compounding Using Certain Peptides" to the White House budget office (OMB) for review. It is not final, and its details are not public.
What is the "ban"?
The FDA put BPC-157 and other peptides on a list of substances that may be too risky for pharmacies to mix (compound).
What happened in July 2026
News reports say a panel of outside FDA advisers voted to loosen limits on 6 of 7 peptides they looked at. FDA staff scientists said none had been studied enough.
What happened in October 2026
- On October 14, the FDA sent an interim access policy to OMB.
- News reports say it may let pharmacies make some peptides, like BPC-157, without being punished. The FDA has not published the details.
- This would not make the peptides FDA approved.
What it means for you
Nothing has changed yet. The peptides are still not approved. Talk to your doctor.
FAQ
Is BPC-157 legal now?
It is still not FDA approved. A new policy is under review.
When will the policy be final?
There is no set date. OMB is reviewing it.
Related pages
We never share doses or tell you where to buy. Always ask your doctor.